These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8710854)

  • 1. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
    Rothe M; Xiong J; Shu HB; Williamson K; Goddard A; Goeddel DV
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8241-6. PubMed ID: 8710854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
    Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
    J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.
    Rothe M; Sarma V; Dixit VM; Goeddel DV
    Science; 1995 Sep; 269(5229):1424-7. PubMed ID: 7544915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    Takeuchi M; Rothe M; Goeddel DV
    J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
    Lee SY; Lee SY; Choi Y
    J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for self-association and receptor recognition of human TRAF2.
    Park YC; Burkitt V; Villa AR; Tong L; Wu H
    Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; PĆ¼schner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
    Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
    Pomerantz JL; Baltimore D
    EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.
    Cheng G; Baltimore D
    Genes Dev; 1996 Apr; 10(8):963-73. PubMed ID: 8608943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.
    Dadgostar H; Cheng G
    J Biol Chem; 1998 Sep; 273(38):24775-80. PubMed ID: 9733779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
    Kaye KM; Devergne O; Harada JN; Izumi KM; Yalamanchili R; Kieff E; Mosialos G
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11085-90. PubMed ID: 8855313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.
    Hsu H; Solovyev I; Colombero A; Elliott R; Kelley M; Boyle WJ
    J Biol Chem; 1997 May; 272(21):13471-4. PubMed ID: 9153189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B.
    Jang IK; Lee ZH; Kim YJ; Kim SH; Kwon BS
    Biochem Biophys Res Commun; 1998 Jan; 242(3):613-20. PubMed ID: 9464265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.
    Jiang Y; Woronicz JD; Liu W; Goeddel DV
    Science; 1999 Jan; 283(5401):543-6. PubMed ID: 9915703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.